EAE動物(wù)模型建立之：

MOG (35-55), Mouse, Rat 大小(xiǎo)鼠髓鞘少突膠質細胞糖蛋白(bái)（35-55）

産品關鍵詞：

MOG (35-55) 髓鞘少突膠質細胞糖蛋白(bái)（35-55）；中樞神經系統（CNS）；Multiple Sclerosis (MS) 多(duō)發性硬化症；實驗性自(zì)身免疫性腦(nǎo)脊髓炎（EAE）；PLP (178-191)；MBP (87-99)；CAS：149635-73-4

産品描述

MOG，英文全名Myelin oligodendrocyte glycoprotein，中文名髓鞘少突膠質細胞糖蛋白(bái)，髓鞘的一(yī)種微量成分，屬于免疫球蛋白(bái)超家族成員(yuán)之一(yī)。也是特定表達于中樞神經系統（CNS）的自(zì)身抗原，誘導多(duō)發性硬化症的原發性脫髓鞘特征。

MOG (35-55)是髓鞘少突膠質細胞糖蛋白(bái)（Myelin Oligodendrocyte Glycoprotein, MOG）的一(yī)個(gè)片段，能(néng)夠誘導齧齒類動物(wù)自(zì)身免疫抗體生(shēng)成，進而産生(shēng)複發-緩解型神經性疾病，表現出大量斑塊狀脫髓鞘病症。MOG (35-55)誘導的實驗性自(zì)身免疫性腦(nǎo)脊髓炎（EAE）是用來研究多(duō)發性硬化症（MS）的一(yī)種重要模型。

[This 21 amino acid peptide is a fragment of Myelin Oligodendrocyte Glycoprotein (MOG) that induces autoantibody production, which in turn produces a relapsing-remitting neurologic disease with extensive plaque-like demyelination in rodents.  This MOG (35-55) induced experimental autoimmune encephalomyelitis serve as a model to study Multiple Sclerosis (MS).]

産品特性

1）   CAS NO：149635-73-4 [net]

2）  同義名：Myelin Oligodendrocyte Glycoprotein Peptide Fragment 35-55 Rat, Mouse;大小(xiǎo)鼠MOG（35-55）；

3）   分子式：C118H177N35O29S

4）   分子量：2581.96 g/mol

5）   純度：≥98%（HPLC）

6）   外觀：白(bái)色凍幹粉

7）   溶解性：溶于水(shuǐ)（0.5-1 mg/ml）

8）   單字母序列：MEVGWYRSPFSRVVHLYRNGK

9）   三字母序列：Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys

産品信息【來自(zì)美國(guó)CSBio的MOG35-55，産品不僅高(gāo)純且含有高(gāo)含量的活性多(duō)肽≥80%，是質量保證的重要參數。廣泛應用于建立EAE動物(wù)模型，有大量的應用文獻支持。目前我司懋康生(shēng)物(wù)有做備貨，大大縮減你的貨期，以及降低(dī)采購成本。本品有特價，歡迎來電(diàn)咨詢，021-54736159，QQ:2971634497】

【溫馨提示】：見(jiàn)我司懋康生(shēng)物(wù)（maokangbio）整理的百日咳毒素PTX産品專題。

【溫馨提示】：見(jiàn)我司懋康生(shēng)物(wù)（maokangbio）整理的弗氏完全佐劑和不完全佐劑産品專題。

引用文獻【由于内容太多(duō)，以下(xià)文獻列表簡化書寫，請根據文章名稱自(zì)行搜索】

Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation. PMID: 24699451. [For active EAE induction, mice were immunized subcutaneously with 100 μg MOG(35-55) (C S Bio Co.) emulsified in CFA (made with 5 mg/ml heat killed M. tuberculosis H37Ra (BD Difco) in incomplete Freund’s adjuvant (BD Difco)). Pertussis toxin (List Biological)]

Treatment of Experimental Autoimmune Encephalomyelitis by Codelivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles. PMID: 24433027 [Mice were immunized with a complete Freund’s adjuvant (CFA) and MOG peptide emulsion along with pertussis toxin, purchased from Hooke Laboratories (Lawrence, MS), per the manufacturer’s suggestions. After immunization, mice were given clinical scores as previously described.MOG35–55 peptide was purchased from CS Bio]

Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet. PMID: 21702922 [Donor mice were anesthetized with tribromoethanol (®Avertin; Sigma Aldrich, St. Louis, MO) 250 mg/kg intraperitoneally (i.p.) and then immunized subcutaneously (s.c.) with a homogenized emulsion of 200 μg/100 μL MOGp35-55 (C.S. Bio)/Complete Freund's Adjuvant (CFA) supplemented with 2 mg/ml of mycobacterium tuberculosis H37RA (MT) (DIFCO Laboratories). 25 μl of emulsion was injected into the bilateral scapular and inguinal areas. In some experiments, the donor mice or the recipient mice were also injected i.p. with 200 ng/200 μL pertussis toxin (PT) (List Biological Laboratories Inc)/phosphate buffered saline (PBS) on the day of immunization and 2 days post immunization.]

The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis. PMID: 23705890 [Mouse myelin oligodendrocyte glycoprotein peptide (MOGp) 35–55 [MEVGWYRSPFSRVVHLYRNGK] was synthesized by CS Bio.To induce active EAE, C57BL/6 female mice were immunized subcutaneously with MOGp35-55 emulsified in an equal volume of complete Freund adjuvant (CFA) (DIFCO Laboratories, Detroit, MI, USA) in each flank. Mice were 4 days, 1, 2, 3, 4, 5, 6, 7, 8, and 20 weeks of age. Immediately after the immunization, and again 48 hours later, mice received an intravenous injection of pertussis toxin (Ptx) in PBS. All animals received an equivalent dose of Ag, adjuvants, and Ptx on a dose per weight basis: Per 20 g bodyweight, 100 μl of vaccine, containing 100 μg MOGp35-55 and 2 mg/ml mycobacterium, as well as 400 ng Ptx were administered.]

Macrophage Migration Inhibitory Factor Potentiates Autoimmune-Mediated Neuroinflammation. PMID: 23797673 [MOG35–55 (MEVGWYRSPFSRVVHLYRNGK) was purchased from C S Bio and was purified by HPLC (purity >95%).C57BL/6 WT and MIF−/− mice were immunized s.c. over four sites on each of the flanks, with 0.1 ml of an emulsion containing 200 μg MOG35–55 in PBS mixed with an equal volume of CFA containing 200 μg heat-killed Mycobacterium tuberculosis, Jamaica strain.]

Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAE. PMID: 29359175 [Mouse myelin oligodendrocyte glycoprotein35–55 (MOGp35–55) (MEVGWYRSPFSRVVHLYRNGK) was synthesized by CS Bio (Menlo Park, CA).Briefly, 8–12 week old male C57BL/6 mice were anesthetized with tribromoethanol (Avertin; Sigma-Aldrich, St. Louis, MO) 250 mg/kg intraperitoneally (i.p.), and subsequently immunized subcutaneously with MOGp35–55 (100 μg/mouse), emulsified in an equal volume of complete Freund adjuvant14 containing 4 mg/mL H37Ra Mycobacterium tuberculosis (Difco; BD, Franklin Lakes, NJ) in each flank. At the time of immunization and 48 hours later, mice received an i.p. injection of 200 ng pertussis toxin in 200 μL PBS. For all experiments, individual animals were observed daily based on the EAE clinical scoring system as follows: 0 = no clinical disease, 1 = loss of tail tone, 2 = mild paraparesis, 3 = paraplegia, 4 = hindlimb and forelimb paralysis, and 5 = moribund or death.]

Lineage-Specific Metabolic Properties and Vulnerabilities of T Cells in the Demyelinating Central Nervous System. PMID: 28507026 [Briefly, male or female (sex-matched within experiments) C57BL/6 mice were immunized subcutaneously with 50 μg of myelin oligodendrocyte glycoprotein peptide 35–55 (MOG35–55) (CSBIO) emulsified at a 1:1 ratio in Complete Freud’s Adjuvant. On days 0 and 2, 250 ng of pertussis toxin (List Biologicals #180) was administered intraperitoneally. Transfer EAE was performed based on previously described protocols.]

ShcA regulates late stages of T cell development and peripheral CD4+ T cell numbers. PMID: 25595778 [For optimal EAE induction, 10-wk-old female mice were immunized s.c. into the lower back with 100 μg myelin oligodendrocyte gp35–55 [MOG(35–55)] peptide (CS Bio), emulsified in an equal volume of CFA (Sigma-Aldrich) supplemented with heat-killed Mycobacterium tuberculosis (clone H37RA; Difco), for a total of 400 μg H37RA/mouse. Mice received 200 ng pertussis toxin (List Biologicals) i.p. on days 0 and 1 after immunization. For suboptimal EAE induction, mice were immunized s.c. with 75 μg MOG(35–55) in CFA supplemented with H37RA but received only a single i.p. injection of 200 ng pertussis toxin on day 0.]

IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. PMID: 26834156. [For EAE induction, mice were immunized subcutaneously with 100 µg MOG35–55 (CS Bio Co.) emulsified in CFA (made with 5 mg/ml heat-killed Mtb H37Ra [BD] in incomplete Freund’s adjuvant [BD]). PTX (List Biological Laboratories) or mutant PTX (mPTX; mutated at two positions in the S1 subunit [R9K and E129A]; List Biological Laboratories) was injected i.p. (300 ng) on days 0 and 2. Mice were monitored for signs of classical EAE for at least 28 d and graded on a standard 0–5 scale, as previously described.]

Repulsive guidance molecule-a is involved in Th17-cell-induced neurodegeneration in autoimmune encephalomyelitis. PMID: 25456136

注意事(shì)項

為(wèi)了您的安全和健康，請穿實驗服并戴一(yī)次性手套操作。

 — —Written/Edited by V. Shallan【版權歸MKBio懋康所有】

上海夢澤生物科技有限公司是一(yī)家涉足于生(shēng)命科學和生(shēng)物(wù)技(jì)術(shù)領域研究的試劑、儀器(qì)和實驗室消耗品與實驗服務工(gōng)作，主要從(cóng)事(shì)細胞生(shēng)物(wù)學、植物(wù)學、分子生(shēng)物(wù)學、免疫學、生(shēng)物(wù)化學、蛋白(bái)組學。生(shēng)物(wù)制藥與診斷試劑研發生(shēng)産等領域。 本公司秉承“以人為(wèi)本，以誠為(wèi)信、合同守信”的經營理念。堅持"品質保障"的原則為(wèi)廣大客戶提供優質産品。